Green Signal Bio Pharma Ipo

Green signal bio pharma ipo

Differenza tra ask e build nel cambio valute sul forex


GreenSignal Bio Pharma Ltd (GSBPL) is an Indian vaccine manufacturing company with global operations. The Chennai-based company manufactures two products:

  1. BCG Vaccine for immunization against Tuberculosis
  2. BCG-ONCO for Immunotherapy (Freeze Dried) BP for the treatment of Urinary Bladder Carcinoma and the brand name for the same is ‘Urovac’.

The company is one of the four companies globally which have been WHO-prequalified to supply the BCG vaccine to UNICEF.

Green signal bio pharma ipo

The company has secured a long term arrangement since November 2015 to supply the BCG vaccine to UNICEF. GSBPL also supplies the BCG vaccine to the Ministry of Health, India pursuant to the tendering process. The company has been successful in obtaining bids for the years 2009-2010, 2010-2011, 2011-12, 2012-13and 2015-2016. It also supplies the BCG vaccine to Indonesia, and Nepal which are countries outside the UNICEF ambit.

Its BCG-ONCO for Immunotherapy drug is distributed throughout India vide commercial arrangements in India and we intend to market this immunotherapy drug in overseas jurisdictions as well.

Presently, the company has made several limited supplies to various countries such Lebanon, Saudi Arabia, Turkey and Switzerland.

GreenSignal Bio Pharma’s business is organized into domestic (i.e.

Green signal bio pharma ipo

Indian) and international operations. For fiscal year 2016, its domestic and international operations accounted for 53.8% and 46.2%, respectively, of its net revenues from operations. The standalone net revenues from operations for the period ended 30 June 2016 was INR10.14 crore and for the years ended 31 March 2016 was INR20.38 crore, respectively.

Green signal bio pharma ipo

The company’s consolidated net revenues from operations grew at a CAGR of 210.7% in the period from fiscal year 2015 to fiscal year 2016.

GreenSignal Bio Pharma has a manufacturing facility located at Pappankuppam Village, Gummidipoondi, Tiruvallur District, Tamil Nadu equipped with advanced equipment dedicated for the manufacturing of live attenuated BCG Vaccine and the BCG-ONCO for immunotherapy.

Promoter of GreenSignal Bio Pharma: P Sundaraparipooranan and P Murali

GreenSignal Bio Pharma IPO details
Subscription Dates9 – 22 November 2016 (Issue withdrawn due to poor response)
Price BandINR68 – 76 per share (Revised from INR76 – 80 per share)
Fresh issueNIL
Offer For Sale14,579,560 shares (INR116.63 crore at upper price band)
Total IPO size14,579,560 shares (INR116.63 crore at upper price band)
Minimum bid (lot size)175 shares
Face Value INR10 per share
Retail Allocation10%
Listing OnBSE, NSE


GreenSignal Bio Pharma’s consolidated financial performance (in INR crore)

Total revenue11.2611.693.526.6020.49
Total expenses11.3111.864.586.6113.55
Profit after tax-0.48-0.50-1.29-0.215.30

GreenSignal Bio Pharma Ltd 
13/A-3, Sai Niketan, Circular Road,
United India Colony, Kodambakkam, Chennai 600024

Phone: +91 44 2472 2244
Fax: +91 33 2472 2233
Email:[email protected]

Bigshare Services Private Ltd 
E2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri East, Mumbai – 400 072
Maharashtra, India

Phone: +91 22 40430200
Fax: +91 22 28475207
[email protected]

GreenSignal Bio Pharma IPO Subscription Details


Subscription (no.

of times, at 5 PM) 

Day 1

Day 2Day 3Day 4Day 5Day 6Day 7Day 8

Day 9


0.00 0.20 0.20

0.01 0.13 0.13


1.587.968.738.748.908.83 8.58 8.46




GreenSignal Bio Pharma IPO allotment status will be available on Bigshare’s website.

Click on this linkto get allotment status.

IPO Opening Date: 9 November 2016

IPO Closing Date: 22 November 2016 (Issue withdrawn due to poor response)

Finalisation of Basis of Allotment:

Initiation of refunds:

Transfer of shares to demat accounts:

Listing Date:

Listing Price on NSE:

Closing Price on NSE:

7 Upcoming IPOs to watch in 2020